By engineering a special molecule to track certain immune cells in the body, scientists at the Stanford University School of Medicine have invented a litmus test for the effectiveness of a newly devised cancer therapy. With the tracer, doctors can theoretically see if a cancer vaccine has successfully galvanized T cells into a protective state, though the research conducted in this study was exclusively in mice. The {read more here}